Urinary lipid and protein oxidation products upon halothane, isoflurane, or sevoflurane anesthesia in humans: Potential biomarkers for a subclinical nephrotoxicity

Biomarkers

Volumn 18, Issue 1, 2013, Pages 73-81

  Orhan, Hilmi ^a,b   Sahin, Altan ^c   Sahin, Gonul ^c   Aypar, Ulku ^c   Vermeulen, Nico P E ^b  

^a EGE UNIVERSITY   (Turkey)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Acetone; Aldehydes; Clinical markers; Dityrosine; Tubular damage

Indexed keywords

ACETALDEHYDE; ACETONE; ALDEHYDE; BUTYRALDEHYDE; FORMALDEHYDE; GLUCOSE; HALOTHANE; HEXANAL; ISOFLURANE; MALONALDEHYDE; O,O' DITYROSINE; PENTANAL; PROPIONALDEHYDE; SEVOFLURANE; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; INHALATION ANESTHESIA; LIPID OXIDATION; LIPID PEROXIDATION; MALE; NEPHROTOXICITY; OXIDATION; PROTEIN OXIDATION; RANDOMIZED CONTROLLED TRIAL;

ACETONE; ALDEHYDES; ANESTHETICS, INHALATION; BIOLOGICAL MARKERS; FEMALE; GLYCOSURIA; HALOTHANE; HUMANS; ISOFLURANE; KIDNEY; KIDNEY DISEASES; LIPIDS; MALE; METHYL ETHERS; OXIDATION-REDUCTION; PROTEINURIA; TYROSINE;

EID: 84872572374     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2012.737026     Document Type: Article

References (44)

1. Awad JA, Horn JL, Roberts LJ 2nd, Franks JJ. (1996). Demonstration of halothane-induced hepatic lipid peroxidation in rats by quantification of F2-isoprostanes. Anesthesiology 84:910-916.
2. Bradford MM. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
3. Crowley JR, Yarasheski K, Leeuwenburgh C, Turk J, Heinecke JW. (1998). Isotope dilution mass spectrometric quantification of 3-nitrotyrosine in proteins and tissues is facilitated by reduction to 3-aminotyrosine. Anal Biochem 259:127-135.
4. Csallany AS, Der Guan M, Manwaring JD, Addis PB. (1984). Free malonaldehyde determination in tissues by high-performance liquid chromatography. Anal Biochem 142:277-283.
5. De Zwart LL, Venhorst J, Groot M, Commandeur JN, Hermanns RC, Meerman JH, Van Baar BL, Vermeulen NP. (1997). Simultaneous determination of eight lipid peroxidation degradation products in urine of rats treated with carbon tetrachloride using gas chromatography with electron-capture detection. J Chromatogr B Biomed Sci Appl 694:277-287.
6. de Zwart LL, Hermanns RC, Meerman JH, Commandeur JN, Salemink PJ, Vermeulen NP. (1998). Evaluation of urinary biomarkers for radical-induced liver damage in rats treated with carbon tetrachloride. Toxicol Appl Pharmacol 148:71-82.
7. de Zwart LL, Meerman JH, Commandeur JN, Vermeulen NP. (1999). Biomarkers of free radical damage applications in experimental animals and in humans. Free Radic Biol Med 26:202-226.
8. Draper HH, McGirr LG, Hadley M. (1986). The metabolism of malondialdehyde. Lipids 21:305-307.
9. Dugan CM, MacDonald AE, Roth RA, Ganey PE. (2010). A mouse model of severe halothane hepatitis based on human risk factors. J Pharmacol Exp Ther 333:364-372.
10. Durak I, Oztürk HS, Dikmen B, Güven C, Cimen MY, Büyükkoçak S, Kaçmaz M, Avci A. (1999). Isoflurane impairs antioxidant defence system in guinea pig kidney. Can J Anaesth 46:797-802.
11. Eger EI 2nd, Koblin DD, Bowland T, Ionescu P, Laster MJ, Fang Z, Gong D, Sonner J, Weiskopf RB. (1997). Nephrotoxicity of sevoflurane versus desflurane anesthesia in volunteers. Anesth Analg 84:160-168.
12. Ekström T, Garberg P, Egestad B, Högberg J. (1988). Recovery of malondialdehyde in urine as a 2,4-dinitrophenylhydrazine derivative analyzed with high-performance liquid chromatography. Chem Biol Interact 66:177-187.
13. Erdem N, Kanbak M, Saricaoglu F, Ocal T, Tanyel C, Ertas N, Berkkan A, Aypar U. (2006). Extrahepatic metabolism and renal effects of sevoflurane in a case of liver transplantation. Transplant Proc 38:1463-1466.
14. Finkelstein MB, Baggs RB, Anders MW. (1992). Nephrotoxicity of the glutathione and cysteine conjugates of 2-bromo-2-chloro-1,1-difluoroethene. J Pharmacol Exp Ther 261:1248-1252.
15. Goldberg ME, Cantillo J, Gratz I, Deal E, Vekeman D, McDougall R, Afshar M, Zafeiridis A, Larijani G. (1999). Dose of compound A, not sevoflurane, determines changes in the biochemical markers of renal injury in healthy volunteers. Anesth Analg 88:437-445.
16. Guyton AC, Hall CE. (1996). Textbook of medical physiology. Philadelphia, PA: W.B. Saunders Company.\
17. Heinecke JW, Hsu FF, Crowley JR, Hazen SL, Leeuwenburgh C, Mueller DM, Rasmussen JE, Turk J. (1999). Detecting oxidative modification of biomolecules with isotope dilution mass spectrometry: Sensitive and quantitative assays for oxidized amino acids in proteins and tissues. Meth Enzymol 300:124-144.
18. Hughes HM, George IM, Evans JC, Rowlands CC, Powell GM, Curtis CG. (1991). The role of the liver in the production of free radicals during halothane anesthesia in the rat. Quantification of N-tert-butylalpha-(4- nitrophenyl)nitrone (PBN)-trapped adducts in bile from halothane as compared with carbon tetrachloride. Biochem J 277 (Pt 3):795-800.
19. Hultman E. (1959). Rapid specific method for determination of aldosaccharides in body fluids. Nature 183:108-109.
20. Iyer RA, Baggs RB, Anders MW. (1997). Nephrotoxicity of the glutathione and cysteine S-conjugates of the sevoflurane degradation product 2-(fluoromethoxy)-1,1,3,3, 3-pentafluoro-1-propene (Compound A) in male Fischer 344 rats. J Pharmacol Exp Ther 283:1544-1551.
21. Iyer RA, Frink EJ Jr, Ebert TJ, Anders MW. (1998). Cysteine conjugate betalyase-dependent metabolism of compound A (2-[fluoromethoxy]-1,1,3,3,3- pentafluoro-1-propene) in human subjects anesthetized with sevoflurane and in rats given compound A. Anesthesiology 88:611-618.
22. Jin L, Davis MR, Kharasch ED, Doss GA, Baillie TA. (1996). Identification in rat bile of glutathione conjugates of fluoromethyl 2,2-difluoro-1- (trifluoromethyl)vinyl ether, a nephrotoxic degradate of the anesthetic agent sevoflurane. Chem Res Toxicol 9:555-561.
23. Kahraman S, Kilinç K, Dal D, Erdem K. (1997). Propofol attenuates formation of lipid peroxides in tourniquet-induced ischaemiareperfusion injury. Br J Anaesth 78:279-281.
24. Kharasch ED. (2008). Adverse drug reactions with halogenated anesthetics. Clin Pharmacol Ther 84:158-162.
25. Kharasch ED, Hankins DC, Fenstamaker K, Cox K. (2000). Human halothane metabolism, lipid peroxidation, and cytochromes P(450)2A6 and P(450)3A4. Eur J Clin Pharmacol 55:853-859.
26. Kennedy SK, Longnecker DE. (1990). History and principles of anesthesiology. In: Goodman Gilman A, Rall TW, Nies AS, Taylor P (eds). The pharmacological basis of therapeutics. New York: Pergamon Press, 269-284.
27. Kücükakin B, Gögenur I, Rosenberg J. (2007). [Melatonin against surgical stress]. Ugeskr Laeg 169:1306-1308.
28. Mazze RI, Callan CM, Galvez ST, Delgado-Herrera L, Mayer DB. (2000). The effects of sevoflurane on serum creatinine and blood urea nitrogen concentrations: A retrospective, twenty-two-center, comparative evaluation of renal function in adult surgical patients. Anesth Analg 90:683-688.
29. Minoda Y, Kharasch ED. (2001). Halothane-dependent lipid peroxidation in human liver microsomes is catalyzed by cytochrome P4502A6 (CYP2A6). Anesthesiology 95:509-514.
30. Musacchio E, Rizzoli V, Bianchi M, Bindoli A, Galzigna L. (1991). Antioxidant action of propofol on liver microsomes, mitochondria and brain synaptosomes in the rat. Pharmacol Toxicol 69:75-77.
31. Nguyen C, Rose NR, Njoku DB. (2008). Trifluoroacetylated IgG4 antibodies in a child with idiosyncratic acute liver failure after first exposure to halothane. J Pediatr Gastroenterol Nutr 47:199-202.
32. Orhan H, Commandeur JN, Sahin G, Aypar U, Sahin A, Vermeulen NP. (2004a). Use of 19F-nuclear magnetic resonance and gas chromatography-electron capture detection in the quantitative analysis of fluorine-containing metabolites in urine of sevofluraneanesthetized patients. Xenobiotica 34:301-316.
33. Orhan H, van Holland B, Krab B, Moeken J, Vermeulen NP, Hollander P, Meerman JH. (2004b). Evaluation of a multi-parameter biomarker set for oxidative damage in man: Increased urinary excretion of lipid, protein and DNA oxidation products after one hour of exercise. Free Radic Res 38:1269-1279.
34. Orhan H, Vermeulen NP, Tump C, Zappey H, Meerman JH. (2004c). Simultaneous determination of tyrosine, phenylalanine and deoxyguanosine oxidation products by liquid chromatographytandem mass spectrometry as non-invasive biomarkers for oxidative damage. J Chromatogr B Analyt Technol Biomed Life Sci 799:245-254.
35. Orhan H, Coolen S, Meerman JH. (2005). Quantification of urinary o,o'-dityrosine, a biomarker for oxidative damage to proteins, by high performance liquid chromatography with triple quadrupole tandem mass spectrometry. A comparison with ion-trap tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 827:104-108.
36. Orhan H, Gurer-Orhan H, Vriese E, Vermeulen NP, Meerman JH. (2006). Application of lipid peroxidation and protein oxidation biomarkers for oxidative damage in mammalian cells. A comparison with two fluorescent probes. Toxicol in Vitro 20:1005-1013.
37. Ray DC, Drummond GB. (1991). Halothane hepatitis. Br J Anaesth 67:84-99.
38. Rosenfeldt F, Wilson M, Lee G, Kure C, Ou R, Braun L, de Haan J. (2012). Oxidative stress in surgery in an ageing population: Pathophysiology and therapy. Exp Gerontol. (epub ahead of print).
39. Sato N, Fujii K, Yuge O, Morio M. (1990). The association of halothaneinduced lipid peroxidation with the anaerobic metabolism of halothane: An in vitro study in guinea pig liver microsomes. Hiroshima J Med Sci 39:1-6.
40. Sato N, Fujii K, Yuge O. (1994). in vivo and in vitro sevoflurane-induced lipid peroxidation in guinea-pig liver microsomes. Pharmacol Toxicol 75:366-370.
41. Tanaka K, Weihrauch D, Kehl F, Ludwig LM, LaDisa JF Jr, Kersten JR, Pagel PS, Warltier DC. (2002). Mechanism of preconditioning by isoflurane in rabbits: A direct role for reactive oxygen species. Anesthesiology 97:1485-1490.
42. Tsukamoto N, Hirabayashi Y, Shimizu R, Mitsuhata H. (1996). The effects of sevoflurane and isoflurane anesthesia on renal tubular function in patients with moderately impaired renal function. Anesth Analg 82:909-913.
43. Wong CH, Liu TZ, Chye SM, Lu FJ, Liu YC, Lin ZC, Chen CH. (2006). Sevoflurane-induced oxidative stress and cellular injury in human peripheral polymorphonuclear neutrophils. Food Chem Toxicol 44:1399-1407.
44. Yoshida K, Okabe E. (1992). Selective impairment of endotheliumdependent relaxation by sevoflurane: Oxygen free radicals participation. Anesthesiology 76:440-447.